Human gut mycobiota tune immunity via CARD9-dependent induction of anti-fungal IgG antibodies
Open accessThe DOI matches its Crossref record; 22 of the 22 references it cites were found in a registry or an index.
Abstract
SUMMARY Antibodies mediate natural and vaccine-induced immunity against viral and bacterial pathogens, whereas fungi represent a widespread kingdom of pathogenic species for which neither vaccine nor neutralizing antibody therapies are clinically available. Here, using a multi-kingdom antibody profiling (multiKAP) approach, we explore the human antibody repertoires against gut commensal fungi (mycobiota). We identify species preferentially targeted by systemic antibodies in humans, with Candida albicans being the major inducer of antifungal immunoglobulin G (IgG). Fungal colonization of the gut induces germinal center (GC)-dependent B cell expansion in extraintestinal lymphoid tissues and generates systemic antibodies that confer protection against disseminated C. albicans or C. auris infection. Antifungal IgG production depends on the innate immunity regulator CARD9 and CARD9+CX3CR1+ macrophages. In individuals with invasive candidiasis, loss-of-function mutations in CARD9 are associated with impaired antifungal IgG responses. These results reveal an important role of gut commensal fungi in shaping the human antibody repertoire through CARD9-dependent induction of host-protective antifungal IgG.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Enterotypes of the human gut microbiome
MetaHIT Consortium (additional members), Arumugam, M., Raes, J., Pelletier, E., Le Paslier, D., Yamada, T., Mende, D. R., Fernandes, G. R., Tap, J., Bruls, T., et al. (2011) · Nature · doi:10.1038/nature09944 · Cited by 7,548
Host–microbe interactions have shaped the genetic architecture of inflammatory bowel disease
The International IBD Genetics Consortium (IIBDGC), Jostins, L., Ripke, S., Weersma, R. K., Duerr, R. H., McGovern, D. P., Hui, K. Y., Lee, J. C., Philip Schumm, L., Sharma, Y., et al. (2012) · Nature · doi:10.1038/nature11582 · Cited by 4,722
Hidden Killers: Human Fungal Infections
Brown, G. D., Denning, D. W., Gow, N. A. R., Levitz, S. M., Netea, M. G., & White, T. C. (2012) · Science Translational Medicine · doi:10.1126/scitranslmed.3004404 · Cited by 4,284
Emerging fungal threats to animal, plant and ecosystem health
Fisher, M. C., Henk, D. A., Briggs, C. J., Brownstein, J. S., Madoff, L. C., McCraw, S. L., & Gurr, S. J. (2012) · Nature · doi:10.1038/nature10947 · Cited by 3,310 · cited 2×
“, 2012), fungi still represent a wide-spread kingdom of deadly pathogens for which neither vaccines nor neutralizing antibody therapies are clinically available (Fisher et al., 2012; Garcia-Solache and Casadevall, 2010; Rudkin et al., 2018).”
Victora, G. D., & Nussenzweig, M. C. (2012) · Annual Review of Immunology · doi:10.1146/annurev-immunol-020711-075032 · Cited by 1,878 · cited 1×
“, 2016), which undergo many cycles of somatic hypermutation (SHM) that are associated with highaffinity and high titers of antibodies (Victora and Nussenzweig, 2012).”
Correlates of protection induced by vaccination
Plotkin, S. A. (2010) · Clinical and Vaccine Immunology · doi:10.1128/cvi.00131-10 · Cited by 1,745 · cited 1×
“Most antibacterial and antiviral vaccines available today are rooted in boosting antibodymediated immunity (Plotkin, 2010).”
Lamas, B., Richard, M. L., Leducq, V., Pham, H.-P., Michel, M.-L., Da Costa, G., Bridonneau, C., Jegou, S., Hoffmann, T. W., Natividad, J. M., et al. (2016) · Nature Medicine · doi:10.1038/nm.4102 · Cited by 1,482
Immunoglobulin A Coating Identifies Colitogenic Bacteria in Inflammatory Bowel Disease
Palm, N. W., de Zoete, M. R., Cullen, T. W., Barry, N. A., Stefanowski, J., Hao, L., Degnan, P. H., Hu, J., Peter, I., Zhang, W., et al. (2014) · Cell · doi:10.1016/j.cell.2014.08.006 · Cited by 1,286 · cited 2×
“Consistent with previously reported luminal IgA reactivity to intestinal bacteria in mice (Bunker et al., 2015; Koch et al., 2016; Palm et al., 2014), roughly half of the intestinal fungi identified by multiKAP were also bound by IgA independent of serum supplementation (Figures 1F and 1G), suggesting that systemic an…”
LeibundGut-Landmann, S., Groß, O., Robinson, M. J., Osorio, F., Slack, E. C., Tsoni, S. V., Schweighoffer, E., Tybulewicz, V., Brown, G. D., Ruland, J., et al. (2007) · Nature Immunology · doi:10.1038/ni1460 · Cited by 1,191
Conti, H. R., Shen, F., Nayyar, N., Stocum, E., Sun, J. N., Lindemann, M. J., Ho, A. W., Hai, J. H., Yu, J. J., Jung, J. W., et al. (2009) · Journal of Experimental Medicine · doi:10.1084/jem.20081463 · Cited by 1,024 · cited 1×
“albicans has been implicated as a potent inducer of Th17 responses in humans and mice; it is bound by host antibodies and, thus, has the potential to induce protective immune responses or trigger inflammation in a context-dependent manner (Bacher et al., 2019; Conti et al., 2009; Huertas et al., 2017; Leonardi et al.,…”
A Homozygous CARD9 Mutation in a Family with Susceptibility to Fungal Infections
Glocker, E.-O., Hennigs, A., Nabavi, M., Schäffer, A. A., Woellner, C., Salzer, U., Pfeifer, D., Veelken, H., Warnatz, K., Tahami, F., et al. (2009) · New England Journal of Medicine · doi:10.1056/nejmoa0810719 · Cited by 800 · cited 1×
“Among genetic factors associated with fungal infections, CARD9 deficiency is the only known human genetic disorder that specifically leads to recurrent severe mucosal and systemic fungal infections without conferring bacterial, parasitic, or viral susceptibility (Cao et al., 2015; Glocker et al., 2009; Lionakis et al.…”
National Institute of Diabetes and Digestive Kidney Diseases Inflammatory Bowel Disease Genetics Consortium (NIDDK IBDGC), Rivas, M. A., United Kingdom Inflammatory Bowel Disease Genetics Consortium, International Inflammatory Bowel Disease Genetics Consortium, Beaudoin, M., Gardet, A., Stevens, C., Sharma, Y., Zhang, C. K., Boucher, G., et al. (2011) · Nature Genetics · doi:10.1038/ng.952 · Cited by 771
Akkermansia muciniphila induces intestinal adaptive immune responses during homeostasis
Ansaldo, E., Slayden, L. C., Ching, K. L., Koch, M. A., Wolf, N. K., Plichta, D. R., Brown, E. M., Graham, D. B., Xavier, R. J., Moon, J. J., et al. (2019) · Science · doi:10.1126/science.aaw7479 · Cited by 566 · cited 6×
“In contrast to previously established microbial flow cytometry-based techniques (Ansaldo et al., 2019; Christmann et al., 2015; Fadlallah et al., 2019; Koch et al., 2016; Palm et al., 2014), multiKAP distinguishes fungi from the more abundant bacteria by their large cell size and the distinct presence of chitin in the…”
InfluentialA Candida auris Outbreak and Its Control in an Intensive Care Setting
Eyre, D. W., Sheppard, A. E., Madder, H., Moir, I., Moroney, R., Quan, T. P., Griffiths, D., George, S., Butcher, L., Morgan, M., et al. (2018) · New England Journal of Medicine · doi:10.1056/nejmoa1714373 · Cited by 517 · cited 1×
“Candida auris is an emerging multidrug-resistant fungal pathogen that is a serious global health threat and is the cause of multiple nosocomial outbreaks worldwide that are associated with unusually high mortality rates (Eyre et al., 2018).”
Human Anti-fungal Th17 Immunity and Pathology Rely on Cross-Reactivity against Candida albicans
Bacher, P., Hohnstein, T., Beerbaum, E., Röcker, M., Blango, M. G., Kaufmann, S., Röhmel, J., Eschenhagen, P., Grehn, C., Seidel, K., et al. (2019) · Cell · doi:10.1016/j.cell.2019.01.041 · Cited by 473
Activation of HIF-1α and LL-37 by commensal bacteria inhibits Candida albicans colonization
Fan, D., Coughlin, L. A., Neubauer, M. M., Kim, J., Kim, M. S., Zhan, X., Simms-Waldrip, T. R., Xie, Y., Hooper, L. V., & Koh, A. Y. (2015) · Nature Medicine · doi:10.1038/nm.3871 · Cited by 426 · cited 4×
“A better understanding of fungus-specific antibody induction is obscured by coexistence of fungi with a dynamic bacterial community whose composition profoundly influences colonization of, and immune responses induced by, newly introduced bacterial or fungal commensals (Fan et al., 2015; Hand et al., 2012; Kim et al.,…”
InfluentialZeng, M. Y., Cisalpino, D., Varadarajan, S., Hellman, J., Warren, H. S., Cascalho, M., Inohara, N., & Núñez, G. (2016) · Immunity · doi:10.1016/j.immuni.2016.02.006 · Cited by 417
Mucosal damage and neutropenia are required for Candida albicans dissemination
Koh, A. Y., Köhler, J. R., Coggshall, K. T., Van Rooijen, N., & Pier, G. B. (2008) · PLoS Pathogens · doi:10.1371/journal.ppat.0040035 · Cited by 360 · cited 3×
“albicans and treated with the chemotherapy drug cyclophosphamide (Cyc) to induce immunosuppression and facilitate gut-to-system fungal dissemination and death (Figure S4B; Koh et al., 2008).”
Maternal IgG and IgA Antibodies Dampen Mucosal T Helper Cell Responses in Early Life
Koch, M. A., Reiner, G. L., Lugo, K. A., Kreuk, L. S. M., Stanbery, A. G., Ansaldo, E., Seher, T. D., Ludington, W. B., & Barton, G. M. (2016) · Cell · doi:10.1016/j.cell.2016.04.055 · Cited by 315 · cited 9×
“In contrast to previously established microbial flow cytometry-based techniques (Ansaldo et al., 2019; Christmann et al., 2015; Fadlallah et al., 2019; Koch et al., 2016; Palm et al., 2014), multiKAP distinguishes fungi from the more abundant bacteria by their large cell size and the distinct presence of chitin in the…”
InfluentialTeng, F., Klinger, C. N., Felix, K. M., Bradley, C. P., Wu, E., Tran, N. L., Umesaki, Y., & Wu, H.-J. J. (2016) · Immunity · doi:10.1016/j.immuni.2016.03.013 · Cited by 281 · cited 4×
“To determine sites of B cell expansion and IgG class switch recombination (CSR) upon intestinal fungal colonization, gut-distal tissue (spleen) and GALT (mesenteric lymph nodes [mLNs] and Peyer’s patches [PPs]) were obtained from fungus-colonized (C. albicans-colonized [+Ca] and S. cerevisiaecolonized [+Sc]) and fungu…”
InfluentialGut Mycobiota in Immunity and Inflammatory Disease
Li, X. V., Leonardi, I., & Iliev, I. D. (2019) · Immunity · doi:10.1016/j.immuni.2019.05.023 · Cited by 246 · cited 1×
“Candida is one of the most common genera of fungal commensals in the healthy human gastrointestinal tract (Li et al., 2019; Nash et al., 2017; Sokol et al., 2017) but also harbors the main opportunistic pathogens that cause disseminated fungal infections with high attributable morbidity and mortality in humans (Brown…”
Self-citationEdwards, J. E., Schwartz, M. M., Schmidt, C. S., Sobel, J. D., Nyirjesy, P., Schodel, F., Marchus, E., Lizakowski, M., DeMontigny, E. A., Hoeg, J., et al. (2018) · Clinical Infectious Diseases · doi:10.1093/cid/ciy185 · Cited by 213
Cited by
Pathogenesis and virulence of Candida albicans
Lopes, J. P., & Lionakis, M. S. (2022) · Virulence · doi:10.1080/21505594.2021.2019950 · Cited by 477
Zhang, F., Aschenbrenner, D., Yoo, J. Y., & Zuo, T. (2022) · The Lancet Microbe · doi:10.1016/s2666-5247(22)00203-8 · Cited by 388
Immune responses to human fungal pathogens and therapeutic prospects
Lionakis, M. S., Drummond, R. A., & Hohl, T. M. (2023) · Nature Reviews Immunology · doi:10.1038/s41577-022-00826-w · Cited by 379
Mucosal fungi promote gut barrier function and social behavior via Type 17 immunity
Leonardi, I., Gao, I. H., Lin, W.-Y., Allen, M., Li, X. V., Fiers, W. D., De Celie, M. B., Putzel, G. G., Yantiss, R. K., Johncilla, M., et al. (2022) · Cell · doi:10.1016/j.cell.2022.01.017 · Cited by 307
Self-citationImmune regulation by fungal strain diversity in inflammatory bowel disease
Li, X. V., Leonardi, I., Putzel, G. G., Semon, A., Fiers, W. D., Kusakabe, T., Lin, W.-Y., Gao, I. H., Doron, I., Gutierrez-Guerrero, A., et al. (2022) · Nature · doi:10.1038/s41586-022-04502-w · Cited by 302
Self-citation
Metadata
- Authors
- Doron, I., Leonardi, I., Li, X. V., Fiers, W. D., Semon, A., Bialt-DeCelie, M., Migaud, M., Gao, I. H., Lin, W.-Y., Kusakabe, T., Puel, A., & Iliev, I. D.
- Venue
- Cell
- Publisher
- Elsevier BV
- Published
- 2021-02
- Volume
- 184
- Issue
- 4
- Pages
- 1017-1031.e14
- ISSN
- 0092-8674 (ISSN-L)
- OpenAlex
- W3127838289
- Cited by
- 210
- References
- 22
- FWCI
- 10.66
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.